Redhill Biopharma Ltd.
Last updated September 27, 2026
Organization details
- Legal name
- Redhill Biopharma Ltd.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Israel
- Headquarters city
- TEL Aviv
- Headquarters country
- Israel
- Ticker symbol
- RDHL
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001553846
Board of directors
-
Dror Ben-Asher · Director · Chief Executive OfficerSince 2026
-
Kenneth Reed · DirectorSince 2026
-
Ofer Tsimchi · DirectorSince 2026
-
Rick D. Scruggs · Director · Chief Commercial OfficerSince 2026
-
Roni Mamluk · DirectorSince 2026
-
Shmuel Cabilly · DirectorSince 2026
Chief executives
Dror Ben-Asher
· Chief Executive Officer
Since March 2026
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $1,413
- 2 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 10, 2026 | Raday Gilead Officer (Chief Operating Officer) | Open-market sale | −14,130,000 | $0.00 | $1,413 |
| Apr 6, 2026 | Raday Gilead Officer (Chief Operating Officer) | Open-market sale | −15,740,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.